Rankings
▼
Calendar
DHR
Danaher Corporation
$139B
Q4 2021 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$8.1B
+20.5% YoY
Gross Profit
$4.9B
60.7% margin
Operating Income
$2.2B
26.4% margin
Net Income
$1.8B
21.9% margin
EPS (Diluted)
$2.39
QoQ Revenue Growth
+12.7%
Cash Flow
Operating Cash Flow
$2.3B
Free Cash Flow
$1.9B
Stock-Based Comp.
$59M
Balance Sheet
Total Assets
$83.2B
Total Liabilities
$38.0B
Stockholders' Equity
$45.2B
Cash & Equivalents
$2.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8.1B
$6.8B
+20.5%
Gross Profit
$4.9B
$4.0B
+25.0%
Operating Income
$2.2B
$1.6B
+34.5%
Net Income
$1.8B
$1.2B
+44.1%
Revenue Segments
Revenue from Contract with Customer, Measurement, Recurring
$6.0B
73%
Revenue from Contract with Customer, Measurement, Nonrecurring
$2.2B
27%
← FY 2021
All Quarters
Q1 2022 →
DHR Q4 2021 Earnings — Danaher Corporation Revenue & Financial Results | Market Cap Arena